Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg
D5892C00016
Approved small_molecule completed
Quick answer
Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg for Chronic Obstructive Pulmonary Disease (COPD) is a Approved program (small_molecule) at AstraZeneca with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca
- Indication
- Chronic Obstructive Pulmonary Disease (COPD)
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed